NHP

Analyst Note: National Healthcare Properties, Inc. (NHP)

Date: 2026-06-13 Current Price: $14.37

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 8.4% (Extreme)

Analysis:

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Secular Exposure: None Named

As of 2026-06-13, NHP is classified as a Tactical, setup-led name. There is no named secular thesis attached to this security at this date. The investment case must be judged strictly on the quality of the immediate setup (which is currently absent) and the underlying business fundamentals. No macro or thematic thesis (e.g., "Silver Tsunami," "Healthcare Infrastructure") is currently active or assigned to this name in the evidence base.

3. Business Overview

Company: National Healthcare Properties, Inc. (NHP) Industry: Real Estate Investment Trust (REIT) Sector: Healthcare Real Estate

Business Model & Operations: NHP operates as a REIT with a diversified portfolio of healthcare real estate assets, organized into two primary divisions:

• Senior Housing Operating Properties (SHOP): The company invests in senior housing communities through the REIT Investment Diversification and Empowerment Act of 2007 ("RIDEA") structure. Under this model, NHP leases qualified healthcare properties on an arm's-length basis to a Taxable REIT Subsidiary (TRS), which is then operated by an eligible independent contractor.
• *Portfolio Data (as of March 31, 2026):* 37 senior housing communities, 3,615 units, located in 29 states.
• *Unit Mix:* 1,895 assisted living, 838 memory care, and 882 independent living units (as of Dec 31, 2025).
• *Revenue Drivers:* Services are predominantly paid for by residents directly or through private insurance, reducing dependence on government reimbursement programs like Medicaid and Medicare.
• *Operators:* 3 eligible independent contractors operate these communities.

• Outpatient Medical Facilities (OMF): NHP owns, manages, and leases single and multi-tenant outpatient facilities.
• *Portfolio Data (as of March 31, 2026):* 130 outpatient medical facilities, approximately 3.7 million square feet of gross leasable area (GLA).
• *Lease Structure:* Tenants pay base rent plus a pro-rata share of property operating expenses and certain capital expenditures.
• *Management:* All OMFs are managed directly by NHP without third-party service providers.

Financial Position (as of March 31, 2026):

• Liquidity: $147.5 million total ($94.7 million undrawn revolver capacity + $52.8 million cash).
• Debt: $1.0 billion total gross borrowings at a weighted-average interest rate of 5.81% and a weighted-average remaining term of 3.6 years.
• Capital Expenditures: $5.3 million for the quarter ended March 31, 2026. Management expects the annual rate for 2026 to be relatively consistent with 2025, excluding potential acquisition or redevelopment costs.

Strategic Direction: Management has stated an expectation that future real estate investments will focus primarily on SHOPs. The company also notes that the SHOP segment NOI increased in Q1 2026 compared to Q1 2025, driven by positive occupancy trends, revenue per occupied room, and lower operating costs following seven SHOP dispositions.

4. Archetype and Conviction

Archetype: Growth Leader (Source: Layer A) Fit Analysis: The name is categorized as a Growth Leader based on its strategic pivot toward SHOPs and the reported NOI growth in that segment. However, the "Growth" classification is currently constrained by the lack of a technical setup and the extreme volatility (8.4% ATR).

Valuation & Fundamentals:

• Forward Consensus EPS: FY1 is $0.17667; FY2 is $0.06.
• Conviction Stack:
• *Thesis Strength:* Low (No named secular thesis; purely tactical).
• *Evidence Quality:* Moderate. The evidence base (E1-E22) provides a clear picture of the asset mix, liquidity, and debt structure as of Q1 2026.
• *Setup Readiness:* None. The coil is not forming or confirmed.
• *Rerating Potential:* Unclear without a confirmed breakout or a named secular catalyst.

ATR Context: The current ATR of 8.4% is Extreme. Historically, this bucket correlates with the highest rate of severe losses. While the business fundamentals (liquidity, NOI growth) appear stable, the price action volatility suggests a lack of consensus or a reaction to significant news (potentially related to the regulatory changes mentioned in E13-E14 regarding the "One Big Beautiful Bill Act of 2025").

5. Invalidating Factors, Strengthening Factors, and Gaps

What Would Invalidate the Case:

• Fundamental: A significant deterioration in SHOP occupancy or a failure to secure independent contractors for the RIDEA structure.
• Regulatory: Further adverse changes to the "One Big Beautiful Bill Act of 2025" that negatively impact private insurance reimbursement or Medicaid rates, given the company's exposure to these programs.

What Would Strengthen the Case:

• Fundamental: Continued NOI growth in the SHOP segment driven by acquisitions or successful redevelopment, as management expects.
• Liquidity: Successful drawdown of the revolver for high-return acquisitions, demonstrating confidence in the growth strategy.

Gaps in Evidence:

• Forward Guidance: While management provided capital expenditure guidance, specific guidance on dividend coverage or FFO (Funds From Operations) growth for the remainder of 2026 is not explicitly detailed in the provided evidence beyond the consensus EPS.
• Regulatory Impact: The evidence mentions the "One Big Beautiful Bill Act of 2025" but does not quantify its specific financial impact on NHP's 2026 results beyond general statements about regulatory uncertainty.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: low Key evidence: 1. Company reports positive SHOP NOI growth and strong liquidity ($147.5M) as of Q1 2026. 2. Strategic focus on SHOP segment aligns with Growth Leader archetype. 3. Forward consensus EPS suggests modest earnings potential ($0.17667 FY1). Sizing hint: Position size should be zero until a technical setup forms and volatility normalizes. Expected path: Management expects capital expenditures to remain consistent with 2025 levels and investments to focus on SHOPs; price action will likely remain volatile until a clear structural level is established. Expected horizon: Indefinite; requires a technical breakout to trigger a new horizon. Failure mode to watch: A sustained close below any future defined support level or a material deterioration in SHOP occupancy rates.